Pulmonology Devices – Market Insights – US

The US pulmonology device market will grow modestly over the forecast period, driven mainly by the faster procedure growth in many bronchoscopy procedures, such as endobronchial valve placement and bronchial biopsy, as well as the adoption of disposable bronchoscopes and other premium-priced technologies such as reusable flexible white light video bronchoscopes and EBUS–TBNA needles. However, a lack of product innovation in some segments will limit the revenue potential of the US pulmonology device market to some degree.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for pulmonology devices in the US from 2019 through 2034.

Rising participation in lung cancer screening programs will drive US pulmonology device market growth.

What are the latest guidelines on lung cancer screening?

What new bills introduced in the US Congress may increase access to lung cancer screening?

Which product segments within the pulmonology device market will directly benefit if these bills are passed?

Product innovations and improvements will drive market growth in some pulmonology device segments.

Which device segments are expected to grow the fastest and which device segments will decline in size?

How have companies been more active in recent years in terms of coming out with new products?

Advanced imaging modalities will support the overall market growth of pulmonology devices.

What have been the recent advances in imaging technology in the field of bronchoscopy?

How will the adoption of these advanced techniques and devices boost sales in the overall market?

Adoption of premium-priced EBUS–TBNA needles over conventional TBNA continues to rise.

Which companies are contributing toward the increased adoption of EBUS–TBNA?

Usage of what kind of scopes supports the rising adoption of EBUS–TBNA needles?

The endobronchial valve is one of the fastest-growing segment in the US pulmonology device market.

What are the key drivers behind the rising adoption of endobronchial valve placement procedures in the US?

How have the market players performed in 2024 in the US?